Emergence of Mutations in SARS-CoV-2 and the long term Covid-19 impact: is it for good or worse?
Main Article Content
Abstract
SARS-CoV-2 is a type of corona virus that infects humans with pneumonia, and it began spreading in Wuhan, China, in late December of last year. So far, there is no cure for the emerging corona virus, and it is spreading rapidly, recording more than 200 million infections and deaths in large numbers. It is possible that infection with the emerging corona virus may be accompanied by some different symptoms, which are: cough, high temperature and shortness of breath. The Corona virus (SARS-CoV-2) has occupied a special importance since it invaded the world in 2020, and perhaps we do not exaggerate if we say that this unprecedented pandemic of the twenty-first century has changed many features of people’s lives in it, and this virus has appeared in several different mutations, as The severity of the virus increased and became more resistant to the vaccine. The aim of this descriptive minireview, generally, is to shed light on the mergence of different mutations in SARS-CoV-2 and the long term of Covid-19 impact.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. World Health Organization. Novel Coronavirus (2019-nCoV) Available at
https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed February 7, 2020.
II. Huang C, Wang Y, Li X, et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395: 497-506.
III. Neumann-Podczaska A, Al-Saad SR, Karbowski LM, Chojnicki M, Tobis S, Wieczorowska-Tobis K. COVID 19 - Clinical Picture in the Elderly Population: A Qualitative Systematic Review. Aging Dis. 2020;11(4):988-1008. Published 2020 Jul 23. doi:10.14336/AD.2020.0620
IV. Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc. 2020;83(3):217-220. doi:10.1097/JCMA.0000000000000270
V. Collins F (2020) Genome Data Help Track Community Spread of COVID-19. NIH Director’s Blog. Available at:
https://directorsblog.nih.gov/2020/07/21/genome-data-helps-track-community-spread-of-covid-19/
VI. Nguyen, T.T., Pathirana, P.N., Nguyen, T. et al. Genomic mutations and changes in protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus). Sci Rep 11, 3487 (2021). https://doi.org/10.1038/s41598-021-83105-3
VII. Chen AT, Altschuler K, Zhan SH, Chan YA, Deverman BE. COVID-19 CG: Tracking SARS-CoV-2 mutations by locations and dates of interest. Preprint. bioRxiv. 2020;2020.09.23.310565. Published 2020 Sep 28. doi:10.1101/2020.09.23.310565
VIII. Covid-19: WHO warns against “vaccine nationalism” or face further virus mutations BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n292
IX. A.A.Dawood .Mutated COVID-19 may foretell a great risk for mankind I n the future. New Microbes and New Infections Volume 35, May 2020, 100673
X. Wu, Y. Peng, B. Huang, X. Ding, X. Wang, P. Niu, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China . Cell Host Microbe (2020), 10.1016/j.chom.2020.02.001
XI. H.A. Rothan, S.N. Byrareddy The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak .J Autoimm (2020), 10.1016/j.jaut.2020.102433
XII. Robinson J, Banerjee I, Leclézio A, Sathian B. COVID-19 and mutations a threat level assessment. Nepal J Epidemiol. 2021;11(1):983-987. Published 2021 Mar 31. doi:10.3126/nje.v11i1.35659
XIII. Mahase E. Covid-19: What have we learnt about the new variant in the UK? BMJ. 2020. December 23;371:m4944. 10.1136/bmj.m4944 PMid:
XIV. Wang P, Nair MS, Liu L, et al. . Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7. Nature. 2021. March 8. 10.1038/s41586-021-03398-2 PMid: .
XV. Almubaid Z, Al-Mubaid H. Analysis and comparison of genetic variants and mutations of the novel coronavirus SARS-CoV-2. Gene Rep. 2021. June;23:101064. 10.1016/j.genrep.2021.101064 PMid: PMCid:
XVI. Tang JW, Toovey OT, Harvey KN, Hui DD. Introduction of the South African SARS-CoV-2 variant 501Y. V2 into the UK. The Journal of infection. 2021. January 17. 10.1016/j.jinf.2021.01.007 PMid: PMCid